Novo Nordisk to invest $6 billion in expanding plant
Obesity drug maker Novo Nordisk said it will spend $6 billion to boost production in Denmark, although its chief executive warned the industry was far from being able to produce enough weight-loss drugs to meet global demand.
Business
• 10 Nov 23
